(1)
Ex-Vivo and in-Vivo Evaluation of Nanostructured Lipid Carrier Loaded With Gemcitabine and Paclitaxel in A549 Lung Cell for Management of Resistant Cancers. Int. J. Pharm. Sci. Drug Res. 2021, 13 (4), 410-417. https://doi.org/10.25004/IJPSDR.2021.130407.